Home > Income Statement > AUROBINDO PHARMA
AD     Remove this Ad

AUROBINDO PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹31,724 Cr₹29,002 Cr₹24,855 Cr₹23,455 Cr₹24,775 Cr

What is the latest Revenue of AUROBINDO PHARMA ?

The latest Revenue ratio of AUROBINDO PHARMA is ₹31,724 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹31,724 Cr
Mar2024₹29,002 Cr
Mar2023₹24,855 Cr
Mar2022₹23,455 Cr
Mar2021₹24,775 Cr

How is Revenue of AUROBINDO PHARMA Trending?

Years Revenue % Change
Mar2025 ₹31,724 Cr
9.39
Mar2024 ₹29,002 Cr
16.68
Mar2023 ₹24,855 Cr
5.97
Mar2022 ₹23,455 Cr
-5.32
Mar2021 ₹24,775 Cr -

Compare Revenue of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹77,592.0 Cr 2.2% 9.4% 16% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,603.0 Cr -5.6% -2.5% -1.7% Stock Analytics
DIVIS LABORATORIES ₹155,485.0 Cr -2.6% -8.7% 1.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,009.0 Cr -7.2% -8% 27.6% Stock Analytics
DR REDDYS LABORATORIES ₹101,628.0 Cr -6.5% -5.4% 3.9% Stock Analytics
CIPLA ₹96,400.8 Cr -4.1% -11.5% -19% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

2.2%

9.4%

16%

SENSEX

-1%

-10.9%

-6%


You may also like the below Video Courses